SHARE: +/-: 0.40 SEK / Bid: 10.40 SEK / Ask: 10.80 SEK / Price: 10.90 SEK / High: 11.00 SEK / Low: 9.94 SEK / Quantity: 9 790 / Turnover: 102 031 SEK / 2018-12-18 16:20 (CET)
Contact
Spago Nanomedical
Scheelevägen 22
SE-223 63 Lund
Sweden
Mats Hansen
CEO
Phone: +46 76 776 4294
mats.hansen@spagonanomedical.se
Oskar Axelsson
CSO
Phone: +46 708 534 400
oskar.axelsson@spagonanomedical.se
Could not find this address. Check it on Google Maps website to make sure it is correct.
Spago Nanomedical develops nanomaterials for improved cancer diagnostics and treatment
-
Tumorad® patent granted in Europe
Dec 4 2018
-
US patent granted for Tumorad®
Jun 26 2018
-
Spago Nanomedical select CTC for the first clinical trial with SpagoPix
May 28 2018
Copyright
© 2016 Spago Nanomedical AB.
All rights reserved
Address
Scheelevägen 22
SE-223 63 Lund, Sweden
